BG Medicine Free Cash Flow TTM:
-21.42M for Dec. 31, 2012BG Medicine Historical Free Cash Flow TTM Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| Dec. 31, 2012 | -21.42M |
| Sept. 30, 2012 | -20.40M |
| June 30, 2012 | -18.95M |
| March 31, 2012 | -17.56M |
| Dec. 31, 2011 | -15.06M |
| Sept. 30, 2011 | -13.25M |
| June 30, 2011 | -11.52M |
| March 31, 2011 | -10.82M |
| Dec. 31, 2010 | -11.49M |
About Free Cash Flow (TTM)
BGMD Free Cash Flow TTM Benchmarks
| Companies | |
|---|---|
| Response Genetics | -8.968M |
| NeoGenomics | -3.095M |
| Vermillion | -10.41M |
BGMD Free Cash Flow TTM Rankings
| Overall |
46th percentile 4085 of 7593 |
| Sector |
28th percentile 467 of 650 in Healthcare |
| Industry |
14th percentile 52 of 61 in Diagnostics & Research |
BGMD Free Cash Flow TTM Range, Past 5 Years
| Minimum | -21.42M | Dec 2012 |
| Maximum | -10.82M | Mar 2011 |
| Average | -15.61M |
BGMD News
BG Medicine, Inc. Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4)
GlobeNewswire May 10
GlobeNewswire May 10